Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov 25:8:1629-34.
doi: 10.2147/PPA.S38830. eCollection 2014.

Alitretinoin for the treatment of severe chronic hand eczema

Affiliations
Review

Alitretinoin for the treatment of severe chronic hand eczema

Thomas King et al. Patient Prefer Adherence. .

Abstract

Chronic hand eczema is a common and often debilitating condition. Alitretinoin, a 9-cis-retinoic acid and pan-retinoic acid agonist, is a new and effective systemic treatment for chronic hand eczema, which provides another treatment option. A "clear" or "almost clear" response can be achieved in up to half of patients within a 24-week course of treatment. Even higher rates of remission can be obtained with a longer duration of treatment. Alitretinoin has a favorable overall profile of adverse effects; however, female patients who are at risk of becoming pregnant should follow a strict pregnancy-prevention program due to the teratogenic effects of this drug.

Keywords: CTCL; dermatitis; toctino.

PubMed Disclaimer

References

    1. English J, Graham-Brown R, de Sica CA, Alexandroff AB. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies. Clin Exp Dermatol. 2011;(Suppl 36):1–2. - PubMed
    1. Alexandroff AB, Johnston GA. Medical management of contact dermatitis. G Ital Dermatol Venereol. 2009;144:537–540. - PubMed
    1. Diepgen TL, Andersen KE, Brandao FM, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009;160:353–358. - PubMed
    1. Castelain M, Assier H, Baeck M, et al. The European Standard Series and its additions: are they of any use in 2013? Eur J Dermatol. 2014 Jan-Feb;24(1):15–22. - PubMed
    1. Schalock PC, Dunnick CA, Nedorost S, et al. American contact dermatitis society core allergen series. Dermatitis. 2013 Jan-Feb;24(1):7–9. - PubMed

LinkOut - more resources